SIRT1 and colitis: Hence, the current study was designed to investigate the potential involvement of the antioxidant/cytoprotective SIRT1/FoxO3a/Nrf2 axis and the pro-inflammatory PI3K/AKT pathway in the ameliorative effects of REB against AA-evoked colitis in rats.